The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2024 | Overview of the disparities in detection of early lung cancer and how we can bridge them
Matthew Smeltzer, PhD, The University of Memphis, Memphis, TN discusses the disparities in detection of early lung cancer and how we can bridge them. First, the criteria used for screening eligibility can create sex-based and race-based disparities. Second, there are disparities in who gets screened from those who are eligible. It is therefore important to create accessible and fair criteria, and to better educate patients about screening. This interview took place during the 2024 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Other Relationship – Association of Community Cancer Centers (ACCC)
